Pharmafile Logo
Pharmafocus logo
Advanced Search

value-based pricing

Showing 15 posts of 23 posts found.

ABPI image

ABPI outlines vision for drug pricing reform

August 3, 2012
Sales and Marketing ABPI, NICE, PPRS, VBP, Whitehead, value-based pricing

The ABPI has set out what it wants to see from the new drug pricing system in the UK. Negotiations …

News

Value-based pricing won’t encourage innovation, says ABPI

September 23, 2011
Sales and Marketing value-based pricing

The ABPI has come out against the government’s reforms of drug pricing in the UK, saying its plans need a …

News

Government seeks to salvage pharma pricing reforms

July 19, 2011
Sales and Marketing NICE, value-based pricing

The government is pushing ahead with plans to introduce value-based pricing in 2014, despite acknowledging the new system still requires …

News

UK pricing reform derailed

July 15, 2011
Sales and Marketing NICE, PPRS, value-based pricing

Plans to revolutionise the pricing of medicines in the UK look to be another casualty in the Department of Health’s …

News

NICE gains expanded role alongside value-based pricing

June 21, 2011
Sales and Marketing NHS reforms, NICE, value-based pricing

NICE will be given a wider remit to oversee social care and its guidance used alongside value-based pricing as part …

News
Cost-effectiveness assessment body NICE

NICE reprieved by government U-turn

June 20, 2011
Sales and Marketing Health and Social Care Bill, NICE, value-based pricing

The government has performed an unexpected U-turn by allowing NICE to retain its powers to decide which new drugs the …

News

VBP: a fait accompli or room for manoeuvre?

April 18, 2011
Sales and Marketing value-based pricing

The pharma industry is seeking a compromise on the UK’s proposed value- based pricing, which promises to revolutionise the country’s …

Feature

Doubts cast on new Cancer Drugs Fund

April 1, 2011
Cancer Drugs Fund, value-based pricing

There are stark regional variations in the number of doctors using the government’s provisional Cancer Drugs Fund, according to a …

News

NHS Confederation: value-based pricing could increase NHS costs

March 18, 2011
Sales and Marketing NHS Confederation, PPRS, Pharmaceutical Price Regulation Scheme, UK drug pricing, VBP, value-based pricing

Government plans to introduce value-based pricing in the UK could increase the NHS drugs bill without improving the effectiveness of …

News
Association of the British Pharmaceutical Industry

Pharma industry wary of UK drug pricing changes

March 17, 2011
Sales and Marketing ABPI, National Voices, PPRS, Pharmaceutical Price Regulation Scheme, Simon Jose, UK drug pricing, VBP, value-based pricing

The ABPI wants the current drug pricing system to remain, but has welcomed government proposals to take a broader view …

News

Value-based pricing will not harm industry, says NICE chief

February 18, 2011
Sales and Marketing Health Select Committee, Health and Social Care Bill, NHS reform, NICE, Sir Andrew Dillon, value-based pricing

NICE’s chief executive Sir Andrew Dillon says he believes plans to introduce value-based pricing of medicines will not have a …

News
Eli Lilly chief executive John Lechleiter

Lilly chief issues warning on UK reforms

February 11, 2011
Research and Development, Sales and Marketing John Lechleiter, US health reforms, healthcare reform, lilly, patent box, value-based pricing

Lilly chief executive John Lechleiter has warned that two key UK initiatives could fall seriously short of encouraging investment in …

News

Cancer Drugs Fund must not be forerunner to value-based pricing – EMIG

January 19, 2011
Sales and Marketing Cancer Drugs Fund, EMIG, Ethical Medicines Industry Group, NHS, value-based pricing

The association representing small to medium UK pharma companies says the forthcoming Cancer Drugs Fund is welcome – but must …

News

Liberating the NHS … whether it likes it or not

December 22, 2010
Sales and Marketing GP consortia, NHS, NHS board, NHS reforms, value-based pricing

When health secretary Andrew Lansley announced plans in July to abolish the management structure of England’s health service, and hand …

Feature

Government consults on UK value-based pricing

December 17, 2010
Sales and Marketing ABPI, Drug pricing, pharma pricing, value-based pricing

The government has begun a consolutation process for its plans to change the way medicines are priced in the UK. …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023